The Gem Aromatics IPO is a closed mainboard Bookbuilding offer (Fresh Capital-cum-Offer for Sale) that opened on 19 August 2025. The Gem Aromatics IPO closed on 21 August 2025, with an issue price of ₹325 per share. The Gem Aromatics IPO has a face value of ₹2 and a lot size of 46 shares. The Gem Aromatics IPO is listed on 26 August 2025. The Gem Aromatics IPO allotment was scheduled for 22 August 2025.
On the financial front, the Gem Aromatics IPO reported revenue of ₹506 crore for 31 Mar 2025, compared with ₹454 crore for 31 Mar 2024. The Gem Aromatics IPO PAT was ₹53 crore against ₹50 crore. The Gem Aromatics IPO EBITDA stood at ₹88 crore with a 17.55% margin. The Gem Aromatics IPO net worth as of 31 Mar 2025 was ₹284 crore.
Always verify The Gem Aromatics IPO details and GMP data with the official offer document before investing in the Gem Aromatics IPO.
Financial Summary
Amount in Crore
Metric
31 Mar 2025
31 Mar 2024
31 Mar 2023
Total Assets
535
369
296
Revenue
506
454
425
PAT
53
50
45
EBITDA
88
78
66
Net Worth
284
231
180
Reserves
278
225
182
Total Borrowing
222
111
89
Gem Aromatics IPO Financials FAQs
Revenue of Gem Aromatics (Amount in Crore) — 31 Mar 2025: 506; 31 Mar 2024: 454; 31 Mar 2023: 425. Profit after tax (PAT) — 31 Mar 2025: 53; 31 Mar 2024: 50; 31 Mar 2023: 45.
EBITDA of Gem Aromatics (Amount in Crore) — 31 Mar 2025: 88; 31 Mar 2024: 78; 31 Mar 2023: 66. The EBITDA margin is 17.55%.
Total assets — 31 Mar 2025: 535; 31 Mar 2024: 369; 31 Mar 2023: 296. Net worth — 31 Mar 2025: 284; 31 Mar 2024: 231; 31 Mar 2023: 180. Reserves & surplus — 31 Mar 2025: 278; 31 Mar 2024: 225; 31 Mar 2023: 182. (Amount in Crore)
Total borrowing of Gem Aromatics (Amount in Crore) — 31 Mar 2025: 222; 31 Mar 2024: 111; 31 Mar 2023: 89. Debt-to-equity ratio: 0.78.
The financials shown for Gem Aromatics IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
